Targeting gut surface proteins in Diaphorina citri by RNA interference reduces uptake of Candidatus Liberibacter asiaticus
Pest Management Science · 2026-06 · 82 (6) · 5266-5279
DOI: 10.1002/ps.70637 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pest Management Science, online erschienen am 08.02.2026. Verfasst von Miltan Chandra Roy und 5 weiteren Autor:innen. Beteiligte Einrichtung: Citrus Research and Education Center, Department of Entomology and Nematology, University of Florida, Lake Alfred, FL, USA. Hauptthemen laut MEDLINE: Hemiptera, RNA Interference, Insect Proteins, Rhizobiaceae. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 91 Literaturangaben. Gefördert von: National Institute of Food and Agriculture.
Abstract (Originalsprache)
BACKGROUND The Asian citrus psyllid, Diaphorina citri , vectors Candidatus Liberibacter asiaticus ( C Las) that causes citrus greening disease, which has devastated global citrus production. Current management primarily relies on the application of synthetic chemical insecticides, resulting in the evolution of resistance among D . citri populations. C Las is ingested by D . citri while feeding on infected plants and subsequently interacts with the gut epithelial surface to establish infection. To determine the functional significance of abundant gut surface proteins in D. citri during C Las uptake, we used RNA interference (RNAi) to silence nine key gut surface protein genes. RESULTS Following membrane feeding on double‐stranded RNAs (dsRNAs), transcript levels were reduced by 20–51% in adults and 28–50% in nymphs at 72 h, with higher knockdown efficiencies of 41–63% in adults and 30–81% in nymphs by 120 h. Some dsRNA treatments increased D. citri mortality by approximately 20% over the control treatment, and two treatments reduced honeydew production indicative of reduced feeding consistent with disrupted gut function. Silencing of several individual proteins, including alkaline phosphatase, cadherin, cluster of calcium‐transporting ATPase, croquemort and monocarboxylate transporter, reduced C Las uptake in nymphs and/or adults. CONCLUSION Silencing of abundant gut surface proteins in D. citri limited C Las uptake, establishing a functional basis for RNAi‐mediated suppression of pathogen uptake. While additional studies are needed to determine specific molecular interactions, these results identify gut surface proteins as promising targets for RNAi‐based interventions to reduce C Las uptake by psyllids. © 2026 Society of Chemical Industry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Citrus Research and Education Center, Department of Entomology and Nematology, University of Florida, Lake Alfred, FL, USA.
- Department of Entomology and Nematology, University of Florida, Gainesville, FL, USA.
- Mid-Florida Research and Education Center, Department of Entomology and Nematology, University of Florida, Apopka, FL, USA.
ORCID-Profile: Kirsten S Pelz-Stelinski, Bryony C Bonning
Förderung
- National Institute of Food and Agriculture
Zitieren
APA
Roy, M. C., Xie, N., Roldan, E. L., Stelinski, L. L., Pelz-Stelinski, K. S., & Bonning, B. C. (2026). Targeting gut surface proteins in Diaphorina citri by RNA interference reduces uptake of Candidatus Liberibacter asiaticus. Pest Management Science, 82(6), 5266-5279. https://doi.org/10.1002/ps.70637
Vancouver
Roy MC, Xie N, Roldan EL, Stelinski LL, Pelz-Stelinski KS, Bonning BC. Targeting gut surface proteins in Diaphorina citri by RNA interference reduces uptake of Candidatus Liberibacter asiaticus. Pest Management Science. 2026;82(6):5266-5279. doi:10.1002/ps.70637
BibTeX
@article{Roy2026,
author = {Roy, Miltan Chandra and Xie, Na and Roldan, Erik L and Stelinski, Lukasz L and Pelz-Stelinski, Kirsten S and Bonning, Bryony C},
title = {Targeting gut surface proteins in Diaphorina citri by RNA interference reduces uptake of Candidatus Liberibacter asiaticus},
journal = {Pest Management Science},
year = {2026},
volume = {82},
number = {6},
pages = {5266--5279},
doi = {10.1002/ps.70637}
}
EUVIMED